EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Human γδ T cells induce CD8+ T cell antitumor responses via antigen-presenting effect through HSP90-MyD88-mediated activation of JNK

Shengdong Wang, Hengyuan Li, Tao Chen, Hao Zhou, Wenkan Zhang, Nong Lin, Xiaohua Yu, Yu Lou, Binghao Li, Eloy Yinwang, Zenan Wang, Keyi Wang und 9 weitere

Cancer Immunology, Immunotherapy · 2023

DOI: 10.1007/s00262-023-03375-w ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Immunology, Immunotherapy, 2023. Verfasst von Shengdong Wang und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, Musculoskeletal Tumor Center, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, 310009, …. Hauptthemen laut MEDLINE: Bone Neoplasms, Osteosarcoma. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Zhejiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Human Vγ9Vδ2 T cells have attracted considerable attention as novel alternative antigen-presenting cells (APCs) with the potential to replace dendritic cells in antitumor immunotherapy owing to their high proliferative capacity and low cost. However, the utility of γδ T cells as APCs to induce CD8 + T cell-mediated antitumor immune response, as well as the mechanism by which they perform APC functions, remains unexplored. In this study, we found that activated Vγ9Vδ2 T cells were capable of inducing robust CD8 + T cell responses in osteosarcoma cells. Activated γδ T cells also effectively suppressed osteosarcoma growth by priming CD8 + T cells in xenograft animal models. Mechanistically, we further revealed that activated γδ T cells exhibited increased HSP90 production, which fed back to upregulate MyD88, followed by JNK activation and a subsequent improvement in CCL5 secretion, leading to enhanced CD8 + T cell cross-priming. Thus, our study suggests that Vγ9Vδ2 T cells represent a promising alternative APC for the development of γδ T cell-based tumor immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bone NeoplasmsOsteosarcomaAnimalsHumansAntigen PresentationAntigen-Presenting CellsAntigensCD8-Positive T-LymphocytesLymphocyte ActivationMyeloid Differentiation Factor 88Receptors, Antigen, T-Cell, gamma-deltaMAP Kinase Kinase 4HSP90 Heat-Shock Proteins

Stichwörter der Autor:innen

Antigen presentationOsteosarcomaTumor immunotherapyγδ T cells

Substanzen

AntigensMyeloid Differentiation Factor 88Receptors, Antigen, T-Cell, gamma-deltaMAP Kinase Kinase 4HSP90AA1 protein, humanHSP90 Heat-Shock Proteins

Autor:innen und Institutionen

  • Department of Orthopedics, Musculoskeletal Tumor Center, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, 310009, People's Republic of China.
  • Institute of Orthopedic Research, Zhejiang University, Hangzhou, 310009, People's Republic of China.
  • Key Laboratory of Motor System Disease Research and Precision Therapy of Zhejiang Province, Hangzhou, Zhejiang, People's Republic of China.
  • Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, People's Republic of China.
  • Institute of Immunology and Department of Orthopaedics of the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310009, People's Republic of China. caizj@zju.edu.cn.
  • Department of Orthopedics, Musculoskeletal Tumor Center, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, 310009, People's Republic of China. yezhaoming@zju.edu.cn.

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Zhejiang Province

Zitieren

APA

Wang, S., Li, H., Chen, T., Zhou, H., Zhang, W., Lin, N., Yu, X., Lou, Y., Li, B., Yinwang, E., Wang, Z., Wang, K., Xue, Y., Qu, H., Lin, P., Sun, H., Teng, W., Mou, H., Chai, X., …, & Ye, Z. (2023). Human γδ T cells induce CD8+ T cell antitumor responses via antigen-presenting effect through HSP90-MyD88-mediated activation of JNK. Cancer Immunology, Immunotherapy. https://doi.org/10.1007/s00262-023-03375-w

Vancouver

Wang S, Li H, Chen T, Zhou H, Zhang W, Lin N, et al. Human γδ T cells induce CD8+ T cell antitumor responses via antigen-presenting effect through HSP90-MyD88-mediated activation of JNK. Cancer Immunology, Immunotherapy. 2023. doi:10.1007/s00262-023-03375-w

BibTeX
@article{Wang2023,
  author = {Wang, Shengdong and Li, Hengyuan and Chen, Tao and Zhou, Hao and Zhang, Wenkan and Lin, Nong and Yu, Xiaohua and Lou, Yu and Li, Binghao and Yinwang, Eloy and Wang, Zenan and Wang, Keyi and Xue, Yucheng and Qu, Hao and Lin, Peng and Sun, Hangxiang and Teng, Wangsiyuan and Mou, Haochen and Chai, Xupeng and Cai, Zhijian and Ye, Zhaoming},
  title = {Human γδ T cells induce CD8+ T cell antitumor responses via antigen-presenting effect through HSP90-MyD88-mediated activation of JNK},
  journal = {Cancer Immunology, Immunotherapy},
  year = {2023},
  doi = {10.1007/s00262-023-03375-w}
}
Kostenlos starten →